![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 223/16 | (2006.01) |
A61K 31/55 | (2006.01) | ||
A61P 3/04 | (2006.01) | ||
A61P 25/30 | (2006.01) | ||
A61P 25/24 | (2006.01) |
(11) | Number of the document | 2327698 |
(13) | Kind of document | T |
(96) | European patent application number | 10010048.6 |
Date of filing the European patent application | 2005-12-20 | |
(97) | Date of publication of the European application | 2011-06-01 |
(45) | Date of publication and mention of the grant of the patent | 2015-08-05 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
638221 P | 2004-12-21 | US |
(72) |
Agarwal, Rajesh Kumar, US
Betts, III William L., US
Henshilwood, James A., US
Kiang, Yuan-Hon, US
Post, Noah, US
|
(73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
(54) | Process for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate |
Process for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate |